Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACLE HIV: Eplerenone for Cardiovascular Health in HIV
NCT02740179Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2017
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in cardiovascular disease (CVD), sponsored by Massachusetts General Hospital. Started Jan 2017; status: completed.
02
Drugs
eplerenone
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02740179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740179.